Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.46 |
| ▸ | CPB2 | Q96IY4 | 6/20 | 0.44 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.40 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.40 |
| ▸ | FURIN | P09958 | 3/20 | 0.39 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.39 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.39 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.39 |
| ▸ | PCSK6 | P29122 | 1/20 | 0.39 |
| ▸ | CTSC | P53634 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30567426 | 0.95 | FOLH1 (0.42) | FOLH1CPB2FURIN | |
| SCHEMBL31474489 | 0.95 | FOLH1 (0.42) | FOLH1CPB2FURIN | |
| SCHEMBL30956312 | 0.93 | FOLH1 (0.47) | FOLH1CPB2SLC6A5SLC15A2ERAP2 | |
| SCHEMBL31396831 | 0.93 | FURIN (0.42) | FOLH1CPB2FURIN | |
| SCHEMBL30093154 | 0.92 | FOLH1 (0.48) | FOLH1CPB2SLC6A5SLC15A2FURIN | |
| SCHEMBL30578949 | 0.92 | FOLH1 (0.48) | FOLH1CPB2SLC6A5SLC15A2FURIN | |
| SCHEMBL29557040 | 0.92 | FOLH1 (0.54) | FOLH1CPB2CTSC | |
| SCHEMBL24130548 | 0.92 | FOLH1 (0.53) | FOLH1CPB2SLC6A5SLC15A2ERAP2 | |
| SCHEMBL8759327 | 0.92 | FOLH1 (0.53) | FOLH1CPB2SLC6A5SLC15A2ERAP2 | |
| SCHEMBL8759318 | 0.92 | FOLH1 (0.53) | FOLH1CPB2SLC6A5SLC15A2ERAP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025002589-A1 | TISSUE EXTRACELLULAR PEPTIDE PATTERNS DEDICATED FOR GENERATION OF ANTI-CANCER VACCINES AGAINST SALIVARY GLAND TUMOR, IDENTIFICATION AND ISOLATION OF SALIVARY GLAND TUMOR SPECIFIC T CELLS IN HUMANS | Uniwersytet Gdański (PL) | 2025-01-02 | — | — | WO | claimed |
| EP-4482853-A1 | ANNEXIN A1-DERIVED POLYPEPTIDE ANALOGUES | RESOTHER PHARMA A/S (DK) | 2025-01-01 | — | — | EP | disclosed |
| WO-2023161323-A1 | ANNEXIN A1-DERIVED POLYPEPTIDE ANALOGUES | RESOTHER PHARMA A/S (DK) | 2023-08-31 | — | — | WO | disclosed |